Michael J. Berna

1.8k total citations
23 papers, 1.3k citations indexed

About

Michael J. Berna is a scholar working on Spectroscopy, Molecular Biology and Immunology. According to data from OpenAlex, Michael J. Berna has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Spectroscopy, 10 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Michael J. Berna's work include Mass Spectrometry Techniques and Applications (9 papers), Analytical Chemistry and Chromatography (6 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Michael J. Berna is often cited by papers focused on Mass Spectrometry Techniques and Applications (9 papers), Analytical Chemistry and Chromatography (6 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Michael J. Berna collaborates with scholars based in United States, Switzerland and India. Michael J. Berna's co-authors include Bradley L. Ackermann, Anthony Murphy, John‐Michael Sauer, George G. Nomikos, Gerald W. Becker, Jingqi Bao, Michael D. Knierman, Christian C. Felder, Amy C. Porter and Frank P. Bymaster and has published in prestigious journals such as Analytical Chemistry, Analytical Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michael J. Berna

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Berna United States 17 496 487 426 255 117 23 1.3k
Nalini Sadagopan United States 15 574 1.2× 530 1.1× 262 0.6× 213 0.8× 145 1.2× 20 1.4k
Norman Huebert United States 21 132 0.3× 356 0.7× 129 0.3× 283 1.1× 76 0.6× 40 1.1k
Edward G. Hawkins United States 11 669 1.3× 345 0.7× 66 0.2× 327 1.3× 95 0.8× 12 1.2k
Darren S. Dumlao United States 19 180 0.4× 675 1.4× 87 0.2× 95 0.4× 295 2.5× 26 1.5k
Sunny E. Ohia United States 20 153 0.3× 462 0.9× 57 0.1× 145 0.6× 289 2.5× 93 1.4k
Kazuhiro Kubo Japan 23 97 0.2× 537 1.1× 39 0.1× 206 0.8× 223 1.9× 130 1.7k
Dongsheng Ouyang China 24 181 0.4× 459 0.9× 39 0.1× 61 0.2× 80 0.7× 59 1.3k
Cristina Amaral Portugal 23 416 0.8× 396 0.8× 27 0.1× 81 0.3× 54 0.5× 57 1.3k
Ai Tsuji Japan 21 319 0.6× 608 1.2× 36 0.1× 150 0.6× 184 1.6× 74 1.6k

Countries citing papers authored by Michael J. Berna

Since Specialization
Citations

This map shows the geographic impact of Michael J. Berna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Berna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Berna more than expected).

Fields of papers citing papers by Michael J. Berna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Berna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Berna. The network helps show where Michael J. Berna may publish in the future.

Co-authorship network of co-authors of Michael J. Berna

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Berna. A scholar is included among the top collaborators of Michael J. Berna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Berna. Michael J. Berna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Anthony, et al.. (2024). Bioanalytical approaches to support the development of antibody-oligonucleotide conjugate (AOC) therapeutic proteins. Xenobiotica. 54(8). 552–562. 2 indexed citations
2.
Walles, Markus, Michael J. Berna, Wenying Jian, et al.. (2022). A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation. Drug Metabolism and Disposition. 50(6). 846–857. 10 indexed citations
3.
Berna, Michael J., et al.. (2014). The interactome of the atypical phosphatase Rtr1 in Saccharomyces cerevisiae. Molecular BioSystems. 10(7). 1730–1741. 30 indexed citations
4.
Berna, Michael J. & Bradley L. Ackermann. (2009). Increased Throughput for Low-Abundance Protein Biomarker Verification by Liquid Chromatography/Tandem Mass Spectrometry. Analytical Chemistry. 81(10). 3950–3956. 33 indexed citations
5.
Engle, Steven K., Philip F. Solter, Kelly M. Credille, et al.. (2009). Detection of Left Ventricular Hypertrophy in Rats Administered a Peroxisome Proliferator–Activated Receptor α/γ Dual Agonist Using Natriuretic Peptides and Imaging. Toxicological Sciences. 114(2). 183–192. 23 indexed citations
6.
Berna, Michael J., et al.. (2008). Quantification of NTproBNP in Rat Serum Using Immunoprecipitation and LC/MS/MS:  a Biomarker of Drug-Induced Cardiac Hypertrophy. Analytical Chemistry. 80(3). 561–566. 52 indexed citations
7.
Ackermann, Bradley L., et al.. (2008). Current Applications of Liquid Chromatography/Mass Spectrometry in Pharmaceutical Discovery After a Decade of Innovation. Annual Review of Analytical Chemistry. 1(1). 357–396. 35 indexed citations
8.
Zhen, Yuejun, Michael J. Berna, Zhiying Jin, et al.. (2007). Quantification of heart fatty acid binding protein as a biomarker for drug‐induced cardiac and musculoskeletal necroses. PROTEOMICS - CLINICAL APPLICATIONS. 1(7). 661–671. 18 indexed citations
9.
Berna, Michael J., et al.. (2007). Strategic Use of Immunoprecipitation and LC/MS/MS for Trace-Level Protein Quantification:  Myosin Light Chain 1, a Biomarker of Cardiac Necrosis. Analytical Chemistry. 79(11). 4199–4205. 81 indexed citations
10.
Ackermann, Bradley L. & Michael J. Berna. (2007). Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers. Expert Review of Proteomics. 4(2). 175–186. 132 indexed citations
11.
12.
13.
Berna, Michael J. & Bradley L. Ackermann. (2006). Quantification of serine enantiomers in rat brain microdialysate using Marfey's reagent and LC/MS/MS. Journal of Chromatography B. 846(1-2). 359–363. 27 indexed citations
14.
Berna, Michael J., Bradley L. Ackermann, & Anthony Murphy. (2004). High-throughput chromatographic approaches to liquid chromatographic/tandem mass spectrometric bioanalysis to support drug discovery and development. Analytica Chimica Acta. 509(1). 1–9. 26 indexed citations
15.
Porter, Amy C., John‐Michael Sauer, Michael D. Knierman, et al.. (2002). Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor. Journal of Pharmacology and Experimental Therapeutics. 301(3). 1020–1024. 441 indexed citations
16.
Ackermann, Bradley L., Michael J. Berna, & Anthony Murphy. (2002). Recent Advances in use of LC/MS/MS for Quantitative High-Throughput Bioanalytical Support of Drug Discovery. Current Topics in Medicinal Chemistry. 2(1). 53–66. 90 indexed citations
17.
Murphy, Anthony, et al.. (2002). Effects of flow rate on high‐throughput quantitative analysis of protein‐precipitated plasma using liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 16(6). 537–543. 16 indexed citations
18.
Berna, Michael J., et al.. (1998). Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry. Journal of Mass Spectrometry. 33(10). 1003–1008. 47 indexed citations
19.
Berna, Michael J., et al.. (1998). Determination of LY355703 in dog and mouse plasma by positive ion liquid chromatography/tandem mass spectrometry with atmospheric pressure chemical ionization. Journal of Mass Spectrometry. 33(2). 138–143. 10 indexed citations
20.
Wu, Danlin, et al.. (1997). An automated multidimensional screening approach for rapid method development in high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 16(1). 57–68. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nalini Sadagopan Breakdown of academic impact, for papers by Norman Huebert Breakdown of academic impact, for papers by Edward G. Hawkins Breakdown of academic impact, for papers by Darren S. Dumlao Breakdown of academic impact, for papers by Sunny E. Ohia Breakdown of academic impact, for papers by Kazuhiro Kubo Breakdown of academic impact, for papers by Dongsheng Ouyang Breakdown of academic impact, for papers by Cristina Amaral Breakdown of academic impact, for papers by Ai Tsuji
Rankless by CCL
2026